Clindamycin should be administered within 6 hours following the onset of an illness or the onset of a recurrence of a skin infection caused by anaerobic and gram-negative cocci. It is necessary to observe appropriate anti-microbial therapy, this does not need to be done on-the-spot.
Cocci caused by other skin pathogens may need to be treated with anti-microbial agents for 12- to 72-hour periods. These agents are generally applied for longer than that for skin infections, and because they are more difficult to detect in the blood, they need to be considered more carefully at an earlier stage.
Antibiotic Dosage (mg/kg) for Clindamycin Drug/Time Clindamycin 0 1–6 hours after initial application 10–16 hours 20 hours 24 hours
Antibiotic Dosage (mg/kg) for Clindamycin Drug/Time Clindamycin 0 2–25 hours after initial application 2–6 hours 30 minutes 1 hour
Antibiotic Dosage (mg/kg) for Clindamycin Drug/Time Clindamycin 0 27–65 hours after initial application 5–23 hours 50 minutes 0 hours
Antibiotic Dosage (mg/kg) for Clindamycin Drug/Time Clindamycin 0 65–100 hours after initial application
Clindamycin may be administered with anti-inflammatory drugs, https://bestpills1.com. This Clindamycin can also be used in patients with systemic infections such as infections caused by Staphylococcus aureus, gram-positive Staphylococcus aureus, streptococcal pathogens, salmonellosis and E. coli. Other indications for use of clindamycin include those diseases in which treatment with antibiotic therapy is not appropriate, as in viral infections of the urinary tract as well as in inflammatory conditions such as atherosclerotic heart disease. Some studies have shown that clindamycin may also be effective in HIV patients. The active compound is administered either orally or rectally, and there are various dosage regimens available, including oral formulations (up to 300 mg once daily), an oral tablet (150 mg) with a half-life of 4 hours (or as recommended by the manufacturer for 10 days, to allow time for elimination of the antibiotic and to prevent side effects), sublingual formulations (0.5 g per dose) and topical formulations (from 0.1 mg to 0.4 mg per gram or 0.1 to 0.6 mg per square millimeter in an appropriate amount). This treatment can be used during acute periods. In patients already on a treatment that is recommended for acute disease, clindamycin is recommended to provide adequate protection at the earliest stage of patients’ course.